News Beckley Canopy Therapeutics raises £7.4m for cannabis R&D Oxford-based biopharma Beckley Canopy Therapeutics has raised £7.4 million to develop a range of cannabis-based products for the treatment of pain and to help tackle
News Trump signs legislation to tackle opiate addiction President Donald Trump has signed new legislation into law that he hopes will “end the scourge” of addiction to opiates in the US.
News Teva holding off launch of opioid addiction drug Drugmaker awaiting outcome of separate court case
News FDA approves Indivior's long-lasting opioid withdrawal thera... Monthly injection will help addicts manage withdrawal symptoms
News Gene therapy firm Kate Tx snapped up by Novartis for $1.1bn Novartis buys gene therapy specialist Kate Therapeutics for $1.1 billion, adding an early-stage rival to Sarepta's muscular dystrophy therapy Elevidys
Sales & Marketing Coming soon: The Life Sciences Industry Report 2025 – insigh... Prepare for 2025 with pharmaphorum’s Life Sciences Report, featuring expert insights on AI in drug development, gene therapy, and top industry trends